Celerion and the Korean Drug Development Fund (KDDF) have entered a collaboration to provide drug development expertise and support for the emerging drug discovery and development industry in South Korea.    The agreement provides the framework for collaborations of mutual benefit to both organizations. Companies funded by KDDF will have access to Celerion’s expertise in early clinical research and bioanalysis, as well as external partner sites. The collaboration will support a sharing of knowle...